Skip to main content

1 Result(s)

within Fei-Fan Liu Remove this filter Allergology Remove this filter

and

  1. No Access

    Article

    Type 2 Biomarkers for the Indication and Response to Biologics in CRSwNP

    Three biologics targeting type 2 inflammation have been approved for the treatment of severe and uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). Nevertheless, around 40–60% of patients do not r...

    Cui-Lian Guo, Fei-Fan Liu, De-Yun Wang, Zheng Liu in Current Allergy and Asthma Reports (2023)